NEWS DETAIL

Director/PDMR Dealings

ECO Animal Health Group plc

(''ECO", the "Company" or the "ECO Group") (AIM: EAH)

Director/PDMR Dealings

ECO Animal Health Group plc, a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has been notified that on 12 May 2022, David Hallas, Chief Executive Officer, purchased 33,000 ordinary shares of 5 pence each ("Ordinary Shares") at a price of 117 pence per share.

Following this transaction, David Hallas' total interest in the Company is 33,000 Ordinary Shares, representing approximately 0.05 per cent. of the Company's issued share capital.

Details of the transactions can be found in the Notification of Dealing Form below.



For further information please contact:

ECO Animal Health Group plc

David Hallas (CEO)

Christopher Wilks (CFO)

 


020 8447 8899

 

IFC Advisory

Graham Herring

Zach Cohen

 

020 3934 6630

 

Singer Capital Markets (Nominated Adviser & Joint Broker)

Mark Taylor

George Tzimas

 

020 7496 3000

Investec (Joint Broker)

Gary Clarence

Alex Penney

Carlo Spingardi

 

Peel Hunt LLP (Joint Broker)

Dr Christopher Golden

James Steel

020 7597 5970

 

 

 

 

020 7418 8900

 

Equity Developments

Hannah Crowe

Matt Evans

020 7065 2692

 

 

About ECO Animal Health

ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

David Hallas

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

ECO Animal Health Group plc

b)

 

LEI

 

 

2138009XN9DJ3YP70B55

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 5 pence each

 



Identification code

GB0032036807 

 


b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

 


 

Price(s)

Volume(s)

 


 

117 pence

 

33,000

 


 

 

 

 

d)

 

Aggregated information

N/A - Single transaction



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

12 May 2022

 

 

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END